Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

CP-060S: a cardioprotective agent with a novel mechanism of action

April 24, 1998

Study finds diuretics with beta-blockers to be most efficient in lowering blood pressure

April 24, 1998

CytRx announces manufacturing agreement with Abbott

April 23, 1998

Searle introduces new formulation of verapamil hydrochloride in Canada

April 23, 1998

Nissan Chem. develops chroman derivatives for cardiac insufficiency

April 22, 1998

Tasosartan international status updated

April 22, 1998

Endothelin antagonists discovered at Ajinomoto

April 22, 1998

Clinical trial of gene therapy to stimulate angiogenesis in angina patients

April 22, 1998

Sanofi discloses cGMP PDE inhibitors for cardiovascular indications

April 21, 1998

Mechanisms mediating the effects of ADM on cardiac contractility

April 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...
Korea targets generics, innovation in drug pricing overhaul
BioWorld
South Korea is moving ahead with its biggest reform of drug review and pricing in more than a decade, reflecting a wider shift across Asian markets to reward...